ciprofloxacin has been researched along with Urinary Tract Diseases in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Ofloxacin was administered to 18 patients and ciprofloxacin to 17 patients suffering from acute or chronic complicated urinary tract infections." | 9.06 | Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections. ( Kromann-Andersen, B; Larsen, V; Pers, C; Rasmussen, F; Sommer, P, 1986) |
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin." | 7.67 | Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987) |
"Ofloxacin was administered to 18 patients and ciprofloxacin to 17 patients suffering from acute or chronic complicated urinary tract infections." | 5.06 | Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections. ( Kromann-Andersen, B; Larsen, V; Pers, C; Rasmussen, F; Sommer, P, 1986) |
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin." | 3.67 | Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ena, J | 1 |
Amador, C | 1 |
Martinez, C | 1 |
Ortiz de la Tabla, V | 1 |
Blázquez, R | 1 |
Menasalvas, A | 1 |
Carpena, I | 1 |
Ramírez, C | 1 |
Guerrero, C | 1 |
Moreno, S | 1 |
Christiano, AP | 1 |
Hollowell, CM | 1 |
Kim, H | 1 |
Kim, J | 1 |
Patel, R | 1 |
Bales, GT | 1 |
Gerber, GS | 1 |
Newsom, SW | 1 |
Kromann-Andersen, B | 1 |
Sommer, P | 1 |
Pers, C | 1 |
Larsen, V | 1 |
Rasmussen, F | 1 |
Fass, RJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer: a Phase III Randomized Trial[NCT03862170] | Phase 3 | 255 participants (Anticipated) | Interventional | 2015-02-10 | Suspended (stopped due to Covid-19 pandemic) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for ciprofloxacin and Urinary Tract Diseases
Article | Year |
---|---|
Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Chi-Square Distribu | 2000 |
Clinical evaluation of ofloxacin versus ciprofloxacin in complicated urinary tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; | 1986 |
4 other studies available for ciprofloxacin and Urinary Tract Diseases
Article | Year |
---|---|
Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli.
Topics: Age Factors; Aged; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Inf | 1995 |
Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Esc | 1999 |
The clinical use of quinolones.
Topics: Ciprofloxacin; Escherichia coli; Feces; Female; Genital Diseases, Female; Genital Diseases, Male; Hu | 1986 |
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Male; Middle Ag | 1987 |